Business Description
Noveris Health Sciences Inc
NAICS : 312310
SIC : 3741
ISIN : CA64157D1087
Total Employee Number:
3Compare
Compare
Traded in other countries / regions
NVRS.CanadaMYCOF.USA0NF1.Germany IPO Date
2015-02-23Description
Noveris Health Sciences Inc is a biotech and life sciences company dedicated to developing and commercializing solutions for treating mental health problems and enhancing vitality. The company has a portfolio of patents it is seeking to commercialize, and is exploring opportunities in the stem cell industry. It is developing the next generation of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.8 | |||||
Equity-to-Asset | -1.1 | |||||
Debt-to-Equity | -0.19 | |||||
Debt-to-EBITDA | 0.23 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 80.6 | |||||
3-Year Book Growth Rate | -32.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.9 | |||||
9-Day RSI | 98.9 | |||||
14-Day RSI | 96.4 | |||||
3-1 Month Momentum % | 51.8 | |||||
6-1 Month Momentum % | 1429.05 | |||||
12-1 Month Momentum % | 1328.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.48 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -60.6 | |||||
Shareholder Yield % | -1.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 302.45 | |||||
ROIC % | -7.6 | |||||
3-Year ROIIC % | 178.71 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 0.7 | |||||
Price-to-Owner-Earnings | 11.8 | |||||
EV-to-EBIT | 45.52 | |||||
EV-to-EBITDA | 45.52 | |||||
EV-to-Forward-Revenue | 0.83 | |||||
EV-to-FCF | -291.2 | |||||
Price-to-GF-Value | 3.85 | |||||
Earnings Yield (Greenblatt) % | 2.2 | |||||
FCF Yield % | -0.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MYCOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Noveris Health Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 1.482 | ||
| Beta | -11.0759 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 3.3 | ||
| Volatility % | 912.65 | ||
| 14-Day RSI | 96.4 | ||
| 14-Day ATR ($) | 0.017345 | ||
| 20-Day SMA ($) | 2 | ||
| 12-1 Month Momentum % | 1328.57 | ||
| 52-Week Range ($) | 0.005 - 2.04 | ||
| Shares Outstanding (Mil) | 58.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Noveris Health Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Noveris Health Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.02:1 Stock Split | 2025-10-21 | 0.19 (+10.45%) | ||
| 0.02:1 Stock Split | 2022-04-21 | 102.50 (+78.26%) | ||
| 0.022222:1 Stock Split | 2019-04-01 | 2,475.02 (-9.54%) |
Show
Entries
Noveris Health Sciences Inc Frequently Asked Questions
What is Noveris Health Sciences Inc(MYCOF)'s stock price today?
The current price of MYCOF is $2.00. The 52 week high of MYCOF is $2.04 and 52 week low is $0.01.
When is next earnings date of Noveris Health Sciences Inc(MYCOF)?
The next earnings date of Noveris Health Sciences Inc(MYCOF) is .
Does Noveris Health Sciences Inc(MYCOF) pay dividends? If so, how much?
Noveris Health Sciences Inc(MYCOF) does not pay dividend.
Guru Commentaries on OTCPK:MYCOF
No articles.
Press Release
Articles on Noveris Health Sciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers